Further analysis showed that the JAK–STAT signalling pathway was involved in the 5‐Fu chemoresistance of CRC via TIMP‐2, which could be inhibited by the targeted small molecule drug LY2784544. This evidence concerns the gene TIMP2 and colorectal carcinoma.